Skip to search.
 FTSE 100 Down 0.67%

Gilead Sciences Inc. (GILD)

-NasdaqGS
115.04 Down 0.97(0.84%) 2 Jul 21:00
Add to Portfolio
Prev Close:116.01
Open:116.33
Bid:114.90 x 500
Ask:115.10 x 3800
1y Target Est:122.00
Beta:0.87
Next Earnings Date:27-Jul-15GILD Earnings announcement
Day's Range:114.91 - 116.49
52wk Range:84.75 - 123.37
Volume:8,831,970
Avg Vol (3m):10,904,000
Market Cap:169.06b
P/E (ttm):13.12
EPS (ttm):8.77
Div & Yield:1.72 (1.40%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.84%169.06b
GSKUp 0.28%102.06b
PFEDown 0.95%205.48b
RHHBYUp 0.09%N/A

Key Statistics

Forward P/E (1 yr):10.42
P/S (ttm):6.20
Ex-Dividend Date:12-Jun-15

Analysts

Annual EPS Est (Dec-15) :10.77
Quarterly EPS Est (Jun-15) :2.64
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.81

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback